July 26, 2024 02:00 AM Eastern Daylight Time PARIS–(BUSINESS WIRE)–Regulatory News: ACTICOR BIOTECH (FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announces the conclusions of the futility analysis of the phase 2/3 GREEN study evaluating glenzocimab as an adjunct […]
Neuro
New Studies Validate the Value of Brainomix AI Technology Across US Stroke Networks
The studies presented this week at the Society of Neurointerventional Surgery (SNIS) underline the company’s rigorous evidence-based approach to developing and validating novel AI solutions that can help to optimize patient care across stroke networks. OXFORD, England and CHICAGO, July…
Imperative Care Announces Clinical Data from the Pivotal Imperative Trial Evaluating the Zoom Reperfusion System for the Treatment of Ischemic Stroke
Late-Breaking Data Presented at SNIS Suggest Lower Rates of Rescue Therapy Than Prior Thrombectomy Trials; Rapid Reperfusion Time; High Rates of Reperfusion July 24, 2024 01:30 PM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that late-breaking data from the Imperative Trial were presented at the Society of […]
TeleSpecialists’ Groundbreaking AI-Focused Stroke Research Published in Frontiers in Stroke Journal
Collaborative research highlights the significance of AI-powered care coordination in acute stroke management FORT MYERS, Fla., July 24, 2024 /PRNewswire/ — TeleSpecialists, LLC, the largest inpatient provider of TeleStroke and TeleNeurology services in the nation, announced the…
MicroVention Announces Release of CLinical EValuation of WEB™ 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms
COLORADO SPRINGS, Colo. & ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, today announced the recently published results of the CLinical EValuation of WEB 17 Device in Intracranial Aneurysms (CLEVER): One Year Effectiveness Results for Ruptured and Unruptured Aneurysms. The CLEVER study was a […]
Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution
YOKNEAM, Israel & COLORADO SPRINGS, Colo.–(BUSINESS WIRE)–Rapid Medical™, a leading developer of advanced endovascular devices, announces the first procedures in the USA with the breakthrough deflectable access platform DRIVEWIRE 24 at the 2024 Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting. With active technology, DRIVEWIRE articulates a wide range of catheters for […]
Radical™ Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery (SNIS) 21st Annual Meeting
Company Simultaneously Announces Close of $20 Million Financing Round, US FDA 510(k) Clearance of Neurovascular Radical Catheter and Initial Post-Market Clinical Experience Company Simultaneously Announces Close of $20 Million Financing Round, US FDA 510(k) Clearance of Neurovascular Radical Catheter and Initial Post-Market Clinical Experience
New Research on Climate Change, Gut Health, and Socioeconomic Status’ Impact on Stroke and Aneurysm Care to Be Presented at Society of NeuroInterventional Surgery’s 21st Annual Meeting
COLORADO SPRINGS, Colo., July 18, 2024 /PRNewswire/ — Neurointerventional surgeons from across the globe will gather at the Society of NeuroInterventional Surgery’s (SNIS) 21st Annual Meeting from July 22 through July 25 in Colorado Springs, Colorado, to present novel research and…
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
July 17, 2024 08:00 AM Eastern Daylight Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc., today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Zoom™ 6F Insert Catheters, the company’s latest innovation in elevating stroke care and the first insert catheters developed specifically for ischemic stroke procedures. The company […]
TeleSpecialists Revolutionizes Stroke Care with Launch of Innovative EMS Integration Service
EMS Integration to enhance door-to-needle times and elevate patient outcomes
FORT MYERS, Fla., July 16, 2024 /PRNewswire/ — TeleSpecialists, LLC, the nation’s largest inpatient provider of TeleStroke and TeleNeurology services, launches its EMS Integration service as an enhancement to its current neurology services. This new service will allow TeleSpecialists’ board-certified neurologists to expedite stroke treatment and improve patient outcomes.
TeleSpecialists introduces the EMS Integration service for EMS and local hospitals, to enhance patient care in telestroke and teleneurology. This program enables physicians to interact with EMS teams, and hospitals simultaneously during patient transport. Early teleneurology involvement reduces door-to-needle times by connecting a neurologist on-screen during transit to conduct essential tests. With improved efficiency and collaboration, patients can receive a CT scan immediately upon arrival at the hospital.
“At TeleSpecialists, we are dedicated to pioneering innovations that enhance patient care. Our EMS Integration service represents a major advancement in our ability to improve patient outcomes, particularly in stroke care,” said Nima Mowzoon, MD, MBA, CEO of TeleSpecialists. “By enabling real-time neurology consultations en route to the hospital, we can significantly expedite treatment times and save more lives. This initiative is a testament to our commitment to leveraging technology to deliver the highest quality care to our communities.”
The introduction of the EMS Integration program emphasizes the organization’s commitment to clinical collaboration and continuous improvement in stroke care. This program aims to establish seamless communication between EMS providers and TeleSpecialists to provide timely and effective care for stroke patients in diverse settings. By integrating EMS into its TeleNeurology processes, the company seeks to optimize the delivery of critical interventions and resources, ultimately improving patient outcomes.
The launch of the EMS Integration program at Oak Hill and Bayonet Point Hospital in Hernando County marks a significant milestone in expanding and enhancing TeleSpecialists’ services. With over 10 years of experience and over one million patients seen, this initiative underscores the company’s commitment to delivering improved outcomes to these communities.
About TeleSpecialists, LLCAs the leader in TeleStroke and TeleNeurology and a reliable provider of exceptional TelePsychiatry services in the US, we lead the industry with unmatched quality, scale, and expertise. We seamlessly integrate cutting-edge technology with compassionate care, always striving to preserve and enhance lives through our commitment to excellence.
SOURCE TeleSpecialists



